Selective estrogen receptor modulators and cardiovascular risk in postmenopausal women : studies into the effects of raloxifene and HMR 3339 on established and emerging cardiovascular risk markers

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions